Skip to main content

Table 2 Benefits and harms of the HPV vaccines: number of pages obtained of clinical study reports from the European Medicines Agency and GlaxoSmithKline

From: Benefits and harms of the human papillomavirus (HPV) vaccines: systematic review with meta-analyses of trial data from clinical study reports

 HPV vaccine manufacturerStudy programme IDTotal pages obtainedEuropean Medicines AgencyGlaxoSmithKline
1GlaxoSmithKlineHPV-001581358130
2GlaxoSmithKlineHPV-0037990799
3GlaxoSmithKlineHPV-00811,45642637193
4GlaxoSmithKlineHPV-01383233827941
5GlaxoSmithKlineHPV-01562905435747
6GlaxoSmithKlineHPV-0239360936
7GlaxoSmithKlineHPV-029154301543
8GlaxoSmithKlineHPV-030135101351
9GlaxoSmithKlineHPV-0314760476
10GlaxoSmithKlineHPV-032291202912
11GlaxoSmithKlineHPV-0335870587
12GlaxoSmithKlineHPV-0354510451
13GlaxoSmithKlineHPV-0389570957
14GlaxoSmithKlineHPV-04028921282764
15GlaxoSmithKlineHPV-058174501745
16GlaxoSmithKlineHPV-063147401474
17GlaxoSmithKlineHPV-0698190819
18Merck Sharp and DohmeV501-0053573570
19Merck Sharp and DohmeV501-013179717970
20Merck Sharp and DohmeV501-0157137130
21Merck Sharp and DohmeV501-018101410140
22Merck Sharp and DohmeV501-019264526450
23Merck Sharp and DohmeV501-020259525950
24Merck Sharp and DohmeV503-0064674670
 Total pages obtained 58,41220,71737,695